Ex Parte ROBL - Page 2


               Appeal No.  2001-1581                                                  Page 2                
               Application No.  08/833,172                                                                  

                                        GROUNDS OF REJECTION1                                               
                      Claims 1, 6, 7, and 12-14 stand rejected under 35 U.S.C. § 112, second                
               paragraph, as being indefinite in the recitation of the term “cycloheteroalkyl”.             
                      Claims 1, 6, 7, and 12-14 stand rejected under 35 U.S.C. § 112, second                
               paragraph, as being indefinite in the definition of “R”, particularly the recitation of      
               the phrase “R can be joined together with the carbon to which it is attached to              
               form a 3 to 7 membered ring which may optionally be fused to a benzene ring” as              
               it appears in the claimed invention.                                                         
                      We affirm.                                                                            
                                            CLAIM GROUPING                                                  
                      According to appellant (Brief, page 5), “[a]ll of the rejected [c]laims 1, 6, 7       
               and 12 to 14 stand or fall together.”  Since all claims stand or fall together, we           
               limit our discussion to representative independent claim 1.  Claims 6, 7 and                 
               12-14 will stand or fall together with claim 1.  In re Young, 927 F.2d 588, 590, 18          
               USPQ2d 1089, 1091 (Fed. Cir. 1991).                                                          
                                               DISCUSSION                                                   
                      As set forth in Amgen Inc. v. Chugai Pharmaceutical Co., Ltd., 927 F.2d               
               1200, 1217, 18 USPQ2d 1016, 1030 (Fed. Cir. 1991):                                           
                            The statute requires that “[t]he specification shall conclude                   
                      with one or more claims particularly pointing out and distinctly                      
                      claiming the subject matter which the applicant regards as his                        
                      invention.”  A decision as to whether a claim is invalid under this                   
                      provision requires a determination whether those skilled in the art                   











               1 We note that the issue regarding the “missing left parenthesis in claim 1” as set forth at page 3 of
               the Answer, was subsequently withdrawn.  See Paper No. 19, mailed March 12, 2001.            





Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007